Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
98.7M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
142M
-
Shares change
-
+3.78M
-
Total reported value, excl. options
-
$949M
-
Value change
-
+$31.1M
-
Put/Call ratio
-
1.1
-
Number of buys
-
56
-
Number of sells
-
-81
-
Price
-
$6.70
Significant Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q4 2023
183 filings reported holding GDRX - GoodRx Holdings, Inc. - Common Stock as of Q4 2023.
GoodRx Holdings, Inc. - Common Stock (GDRX) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 142M shares
.
Largest 10 shareholders include Francisco Partners Management, LP (84.7M shares), VANGUARD GROUP INC (8.38M shares), AMERIPRISE FINANCIAL INC (7M shares), Rubric Capital Management LP (5.87M shares), Silver Lake Group, L.L.C. (3.53M shares), RENAISSANCE TECHNOLOGIES LLC (2.98M shares), MORGAN STANLEY (2.27M shares), LAKEWOOD CAPITAL MANAGEMENT, LP (2.21M shares), Petrus Trust Company, LTA (2.2M shares), and BlackRock Inc. (1.85M shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.